Prevalence, Detection, and Management of the Metabolic Syndrome in Patients with Acute Myocardial Infarction: Role of an Obesity-Centric Definition
Table 2
Characteristics of patients with and without IDF MS.
Baseline Characteristic
IDF MS ()
No. MS ()
value
Age
59.7 12.9
58.9 12.7
NS
Male
44 (76)
42 (86)
NS
Hypertension
38 (66)
13 (27)
.001
Smoking
20 (35)
22 (45)
NS
Diabetes mellitus
15 (26)
5 (10)
.03
Family history
20 (35)
14 (29)
NS
Dyslipidaemia
21 (36)
22 (45)
NS
New IFG
29 (50)
13 (27)
.02
Waist Circumference
107.8 13.2
92.8 17.9
.001
Height
1.7 0.1
1.7 0.1
NS
Hip
104.1 17.5
97.6 16.9
.056
Weight
89.0 17.4
74.9 14.6
.001
BMI
31.2 5.9
27.9 10.5
.048
Waist:Hip
1.18 1.31
0.96 0.96
NS
Systolic BP
113.8 16.3
111.6 13.8
NS
Diastolic BP
67.4 10.8
66.3 7.9
NS
Proximal LAD Disease
29 (52)
26 (54)
NS
Extent CAD
NS
1 VD
14 (25)
18 (37)
2 VD
20 (36)
16 (33)
3 VD
22 (38)
14 (29)
Final TIMI 3 flow
50 (91)
42 (88)
NS
LVEF
43.7 7.4
42.5 8.8
NS
DT
174.0 61.7
206.0 58.0
.02
5.2 1.6
6.5 2.0
.04
E to ratio
13.9 5.0
12.4 4.8
NS
Fasting Glucose
6.8 2.6
5.6 0.8
.002
TC
4.8 1.5
4.4 0.9
NS
HDL
0.9 0.3
1.1 0.3
.01
LDL
3.1 1.3
2.8 0.8
NS
Trig
1.7 0.9
1.2 0.7
.001
Data are presented mean SD or (%). BMI: body mass index; CAD: coronary artery disease; DT: deceleration time; HDL: high-density lipoprotein; IFG: impaired fasting glucose; LAD: left anterior descending artery; LDL: low-density lipoprotein; LVEF: left ventricular ejection fraction; TC: total cholesterol; VD: vessels diseased.
